▶ 調査レポート

プラズマ治療薬の世界市場 2020年

• 英文タイトル:Global Plasma Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。プラズマ治療薬の世界市場 2020年 / Global Plasma Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / GIR201114862資料のイメージです。• レポートコード:GIR201114862
• 出版社/出版日:GlobalInfoResearch / 2020年10月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、プラズマ治療薬の世界市場を調査対象にし、プラズマ治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(ヒト血清タンパク質、血漿由来凝固因子、免疫グロブリン、高免疫グロブリン)、用途別分析(研究所・機関、病院、独立型血液バンク)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Baxter、Antares Pharma、Octapharma、CSL Behring、Amag Pharmaceuticals、Grifols Therapeutics、Bio Products Laboratory、ADMA Biologics、Abeona Therapeutics、BioDelivery Sciences、Biota Pharmaceuticals、Biotest Pharmaceuticals、China Biologic Products
・企業別売上、市場シェア
・プラズマ治療薬の地域別市場分析
・プラズマ治療薬の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・プラズマ治療薬のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・プラズマ治療薬のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・プラズマ治療薬の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・プラズマ治療薬の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・プラズマ治療薬の種類別市場規模2015-2020:ヒト血清タンパク質、血漿由来凝固因子、免疫グロブリン、高免疫グロブリン
・プラズマ治療薬の用途別市場規模2015-2020:研究所・機関、病院、独立型血液バンク
・プラズマ治療薬の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The global Plasma Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Plasma Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Plasma Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Plasma Therapeutics market has been segmented into:
Human Serum Protein
Plasma-Derived Clotting Factor
Immunoglobulins
High Immunoglobulins

By Application, Plasma Therapeutics has been segmented into:
Research Laboratories And Institutions
Hospitals
Stand-Alone Blood Banks

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Plasma Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Plasma Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Plasma Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Plasma Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Plasma Therapeutics Market Share Analysis
Plasma Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Plasma Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Plasma Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Plasma Therapeutics are:
Baxter
Antares Pharma
Octapharma
CSL Behring
Amag Pharmaceuticals
Grifols Therapeutics
Bio Products Laboratory
ADMA Biologics
Abeona Therapeutics
BioDelivery Sciences
Biota Pharmaceuticals
Biotest Pharmaceuticals
China Biologic Products

レポート目次

Table of Contents

1 Plasma Therapeutics Market Overview
1.1 Product Overview and Scope of Plasma Therapeutics
1.2 Classification of Plasma Therapeutics by Type
1.2.1 Global Plasma Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Plasma Therapeutics Revenue Market Share by Type in 2019
1.2.3 Human Serum Protein
1.2.4 Plasma-Derived Clotting Factor
1.2.5 Immunoglobulins
1.2.6 High Immunoglobulins
1.3 Global Plasma Therapeutics Market by Application
1.3.1 Overview: Global Plasma Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research Laboratories And Institutions
1.3.3 Hospitals
1.3.4 Stand-Alone Blood Banks
1.4 Global Plasma Therapeutics Market by Regions
1.4.1 Global Plasma Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Plasma Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Plasma Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Plasma Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Plasma Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Plasma Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Plasma Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Baxter SWOT Analysis
2.1.4 Baxter Product and Services
2.1.5 Baxter Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Antares Pharma
2.2.1 Antares Pharma Details
2.2.2 Antares Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Antares Pharma SWOT Analysis
2.2.4 Antares Pharma Product and Services
2.2.5 Antares Pharma Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Octapharma
2.3.1 Octapharma Details
2.3.2 Octapharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Octapharma SWOT Analysis
2.3.4 Octapharma Product and Services
2.3.5 Octapharma Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 CSL Behring
2.4.1 CSL Behring Details
2.4.2 CSL Behring Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CSL Behring SWOT Analysis
2.4.4 CSL Behring Product and Services
2.4.5 CSL Behring Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Amag Pharmaceuticals
2.5.1 Amag Pharmaceuticals Details
2.5.2 Amag Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Amag Pharmaceuticals SWOT Analysis
2.5.4 Amag Pharmaceuticals Product and Services
2.5.5 Amag Pharmaceuticals Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Grifols Therapeutics
2.6.1 Grifols Therapeutics Details
2.6.2 Grifols Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Grifols Therapeutics SWOT Analysis
2.6.4 Grifols Therapeutics Product and Services
2.6.5 Grifols Therapeutics Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bio Products Laboratory
2.7.1 Bio Products Laboratory Details
2.7.2 Bio Products Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bio Products Laboratory SWOT Analysis
2.7.4 Bio Products Laboratory Product and Services
2.7.5 Bio Products Laboratory Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 ADMA Biologics
2.8.1 ADMA Biologics Details
2.8.2 ADMA Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ADMA Biologics SWOT Analysis
2.8.4 ADMA Biologics Product and Services
2.8.5 ADMA Biologics Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abeona Therapeutics
2.9.1 Abeona Therapeutics Details
2.9.2 Abeona Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abeona Therapeutics SWOT Analysis
2.9.4 Abeona Therapeutics Product and Services
2.9.5 Abeona Therapeutics Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 BioDelivery Sciences
2.10.1 BioDelivery Sciences Details
2.10.2 BioDelivery Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 BioDelivery Sciences SWOT Analysis
2.10.4 BioDelivery Sciences Product and Services
2.10.5 BioDelivery Sciences Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Biota Pharmaceuticals
2.11.1 Biota Pharmaceuticals Details
2.11.2 Biota Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Biota Pharmaceuticals SWOT Analysis
2.11.4 Biota Pharmaceuticals Product and Services
2.11.5 Biota Pharmaceuticals Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Biotest Pharmaceuticals
2.12.1 Biotest Pharmaceuticals Details
2.12.2 Biotest Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Biotest Pharmaceuticals SWOT Analysis
2.12.4 Biotest Pharmaceuticals Product and Services
2.12.5 Biotest Pharmaceuticals Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.13 China Biologic Products
2.13.1 China Biologic Products Details
2.13.2 China Biologic Products Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 China Biologic Products SWOT Analysis
2.13.4 China Biologic Products Product and Services
2.13.5 China Biologic Products Plasma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Plasma Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Plasma Therapeutics Players Market Share
3.2.2 Top 10 Plasma Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Plasma Therapeutics Revenue and Market Share by Regions
4.2 North America Plasma Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Plasma Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Plasma Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Plasma Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Plasma Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Plasma Therapeutics Revenue by Countries
5.1 North America Plasma Therapeutics Revenue by Countries (2015-2020)
5.2 USA Plasma Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Plasma Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Plasma Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Plasma Therapeutics Revenue by Countries
6.1 Europe Plasma Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Plasma Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Plasma Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Plasma Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Plasma Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Plasma Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Plasma Therapeutics Revenue by Countries
7.1 Asia-Pacific Plasma Therapeutics Revenue by Countries (2015-2020)
7.2 China Plasma Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Plasma Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Plasma Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Plasma Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Plasma Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Plasma Therapeutics Revenue by Countries
8.1 South America Plasma Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Plasma Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Plasma Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Plasma Therapeutics by Countries
9.1 Middle East & Africa Plasma Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Plasma Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Plasma Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Plasma Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Plasma Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Plasma Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Plasma Therapeutics Market Forecast by Type (2019-2024)
10.3 Human Serum Protein Revenue Growth Rate (2015-2025)
10.4 Plasma-Derived Clotting Factor Revenue Growth Rate (2015-2025)
10.5 Immunoglobulins Revenue Growth Rate (2015-2025)
10.6 High Immunoglobulins Revenue Growth Rate (2015-2025)
11 Global Plasma Therapeutics Market Segment by Application
11.1 Global Plasma Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Plasma Therapeutics Market Forecast by Application (2019-2024)
11.3 Research Laboratories And Institutions Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Stand-Alone Blood Banks Revenue Growth (2015-2020)
12 Global Plasma Therapeutics Market Size Forecast (2021-2025)
12.1 Global Plasma Therapeutics Market Size Forecast (2021-2025)
12.2 Global Plasma Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Plasma Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Plasma Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Plasma Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Plasma Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Plasma Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Plasma Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Plasma Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Plasma Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Plasma Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Baxter Corporate Information, Location and Competitors
Table 6. Baxter Plasma Therapeutics Major Business
Table 7. Baxter Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Baxter SWOT Analysis
Table 9. Baxter Plasma Therapeutics Product and Solutions
Table 10. Baxter Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Antares Pharma Corporate Information, Location and Competitors
Table 12. Antares Pharma Plasma Therapeutics Major Business
Table 13. Antares Pharma Plasma Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Antares Pharma SWOT Analysis
Table 15. Antares Pharma Plasma Therapeutics Product and Solutions
Table 16. Antares Pharma Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Octapharma Corporate Information, Location and Competitors
Table 18. Octapharma Plasma Therapeutics Major Business
Table 19. Octapharma Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Octapharma SWOT Analysis
Table 21. Octapharma Plasma Therapeutics Product and Solutions
Table 22. Octapharma Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. CSL Behring Corporate Information, Location and Competitors
Table 24. CSL Behring Plasma Therapeutics Major Business
Table 25. CSL Behring Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. CSL Behring SWOT Analysis
Table 27. CSL Behring Plasma Therapeutics Product and Solutions
Table 28. CSL Behring Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Amag Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Amag Pharmaceuticals Plasma Therapeutics Major Business
Table 31. Amag Pharmaceuticals Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Amag Pharmaceuticals SWOT Analysis
Table 33. Amag Pharmaceuticals Plasma Therapeutics Product and Solutions
Table 34. Amag Pharmaceuticals Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Grifols Therapeutics Corporate Information, Location and Competitors
Table 36. Grifols Therapeutics Plasma Therapeutics Major Business
Table 37. Grifols Therapeutics Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Grifols Therapeutics SWOT Analysis
Table 39. Grifols Therapeutics Plasma Therapeutics Product and Solutions
Table 40. Grifols Therapeutics Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bio Products Laboratory Corporate Information, Location and Competitors
Table 42. Bio Products Laboratory Plasma Therapeutics Major Business
Table 43. Bio Products Laboratory Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Bio Products Laboratory SWOT Analysis
Table 45. Bio Products Laboratory Plasma Therapeutics Product and Solutions
Table 46. Bio Products Laboratory Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. ADMA Biologics Corporate Information, Location and Competitors
Table 48. ADMA Biologics Plasma Therapeutics Major Business
Table 49. ADMA Biologics Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. ADMA Biologics SWOT Analysis
Table 51. ADMA Biologics Plasma Therapeutics Product and Solutions
Table 52. ADMA Biologics Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abeona Therapeutics Corporate Information, Location and Competitors
Table 54. Abeona Therapeutics Plasma Therapeutics Major Business
Table 55. Abeona Therapeutics Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Abeona Therapeutics SWOT Analysis
Table 57. Abeona Therapeutics Plasma Therapeutics Product and Solutions
Table 58. Abeona Therapeutics Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. BioDelivery Sciences Corporate Information, Location and Competitors
Table 60. BioDelivery Sciences Plasma Therapeutics Major Business
Table 61. BioDelivery Sciences Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. BioDelivery Sciences SWOT Analysis
Table 63. BioDelivery Sciences Plasma Therapeutics Product and Solutions
Table 64. BioDelivery Sciences Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Biota Pharmaceuticals Corporate Information, Location and Competitors
Table 66. Biota Pharmaceuticals Plasma Therapeutics Major Business
Table 67. Biota Pharmaceuticals Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Biota Pharmaceuticals SWOT Analysis
Table 69. Biota Pharmaceuticals Plasma Therapeutics Product and Solutions
Table 70. Biota Pharmaceuticals Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Biotest Pharmaceuticals Corporate Information, Location and Competitors
Table 72. Biotest Pharmaceuticals Plasma Therapeutics Major Business
Table 73. Biotest Pharmaceuticals Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 74. Biotest Pharmaceuticals SWOT Analysis
Table 75. Biotest Pharmaceuticals Plasma Therapeutics Product and Solutions
Table 76. Biotest Pharmaceuticals Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. China Biologic Products Corporate Information, Location and Competitors
Table 78. China Biologic Products Plasma Therapeutics Major Business
Table 79. China Biologic Products Plasma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 80. China Biologic Products SWOT Analysis
Table 81. China Biologic Products Plasma Therapeutics Product and Solutions
Table 82. China Biologic Products Plasma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Plasma Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 84. Global Plasma Therapeutics Revenue Share by Players (2015-2020)
Table 85. Global Plasma Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Plasma Therapeutics Revenue Market Share by Regions (2015-2020)
Table 87. North America Plasma Therapeutics Revenue by Countries (2015-2020)
Table 88. North America Plasma Therapeutics Revenue Market Share by Countries (2015-2020)
Table 89. Europe Plasma Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Plasma Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Plasma Therapeutics Revenue by Countries (2015-2020)
Table 92. South America Plasma Therapeutics Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Plasma Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Plasma Therapeutics Revenue Market Share by Countries (2015-2020)
Table 95. Global Plasma Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 96. Global Plasma Therapeutics Revenue Share by Type (2015-2020)
Table 97. Global Plasma Therapeutics Revenue Forecast by Type (2021-2025)
Table 98. Global Plasma Therapeutics Revenue by Application (2015-2020)
Table 99. Global Plasma Therapeutics Revenue Share by Application (2015-2020)
Table 100. Global Plasma Therapeutics Revenue Forecast by Application (2021-2025)
Table 101. Global Plasma Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Plasma Therapeutics Picture
Figure 2. Global Plasma Therapeutics Revenue Market Share by Type in 2019
Figure 3. Human Serum Protein Picture
Figure 4. Plasma-Derived Clotting Factor Picture
Figure 5. Immunoglobulins Picture
Figure 6. High Immunoglobulins Picture
Figure 7. Plasma Therapeutics Revenue Market Share by Application in 2019
Figure 8. Research Laboratories And Institutions Picture
Figure 9. Hospitals Picture
Figure 10. Stand-Alone Blood Banks Picture
Figure 11. Global Plasma Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Plasma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Plasma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Plasma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Plasma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Plasma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Plasma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Plasma Therapeutics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Plasma Therapeutics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Plasma Therapeutics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Plasma Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Plasma Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Plasma Therapeutics Revenue Market Share by Regions in 2018
Figure 25. North America Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. South America Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. North America Plasma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Plasma Therapeutics Revenue Market Share by Countries in 2019
Figure 32. USA Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Plasma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Plasma Therapeutics Revenue Market Share by Countries in 2019
Figure 37. Germany Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. UK Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. France Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Plasma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Plasma Therapeutics Revenue Market Share by Countries in 2019
Figure 44. China Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. India Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. South America Plasma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Plasma Therapeutics Revenue Market Share by Countries in 2019
Figure 51. Brazil Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Plasma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Plasma Therapeutics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Plasma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Global Plasma Therapeutics Revenue Share by Type (2015-2020)
Figure 60. Global Plasma Therapeutics Revenue Share by Type in 2019
Figure 61. Global Plasma Therapeutics Market Share Forecast by Type (2021-2025)
Figure 62. Global Human Serum Protein Revenue Growth Rate (2015-2020)
Figure 63. Global Plasma-Derived Clotting Factor Revenue Growth Rate (2015-2020)
Figure 64. Global Immunoglobulins Revenue Growth Rate (2015-2020)
Figure 65. Global High Immunoglobulins Revenue Growth Rate (2015-2020)
Figure 66. Global Plasma Therapeutics Revenue Share by Application (2015-2020)
Figure 67. Global Plasma Therapeutics Revenue Share by Application in 2019
Figure 68. Global Plasma Therapeutics Market Share Forecast by Application (2021-2025)
Figure 69. Global Research Laboratories And Institutions Revenue Growth Rate (2015-2020)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Stand-Alone Blood Banks Revenue Growth Rate (2015-2020)
Figure 72. Global Plasma Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Plasma Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Plasma Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Plasma Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Europe Plasma Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Plasma Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. South America Plasma Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Plasma Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel